Literature DB >> 20154286

Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine.

David R Czuchlewski1, Monica Brackney, Christina Ewers, Jonaki Manna, M Houman Fekrazad, Afton Martinez, Kurt B Nolte, Brian Hjelle, Ian Rabinowitz, Brian R Curtis, Janice G McFarland, Joan Baumbach, Kathryn Foucar.   

Abstract

Levamisole is a known contaminant of cocaine and, via this route, has been associated with otherwise unexplained agranulocytosis. Levamisole is currently present in the majority of cocaine samples seized by the US Drug Enforcement Agency. We identified 20 cases of unexplained agranulocytosis in our practice locations of Albuquerque, NM, and Vancouver, Canada. Epidemiologic investigation revealed recent or ongoing cocaine use in 14 cases (70%). Certain morphologic features, including circulating plasmacytoid lymphocytes, increased bone marrow plasma cells, and mild megakaryocytic hyperplasia, were associated with the cocaine-exposed group. Of 5 patients tested, 3 (60%) were HLA-B27+ and showed antineutrophil antibodies, consistent with known associations of levamisole-induced agranulocytosis. One patient, who was positive for cocaine and levamisole by toxicology testing, died of infectious complications. Inadvertent consumption of levamisole via cocaine is a severely under-appreciated risk factor for agranulocytosis, and specific laboratory features are suggestive of this etiology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20154286     DOI: 10.1309/AJCPOPQNBP5THKP1

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  19 in total

Review 1.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

Review 2.  Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: a case report and review of the literature.

Authors:  Shuchi Gulati; Anthony A Donato
Journal:  J Thromb Thrombolysis       Date:  2012-07       Impact factor: 2.300

Review 3.  Cutaneous vasculopathy associated with levamisole-adulterated cocaine.

Authors:  Huy Tran; Debbie Tan; Thomas P Marnejon
Journal:  Clin Med Res       Date:  2012-06-21

Review 4.  Cocaine-Levamisole-Induced Vasculitis/Vasculopathy Syndrome.

Authors:  Javier Marquez; Lina Aguirre; Carolina Muñoz; Andres Echeverri; Mauricio Restrepo; Luis F Pinto
Journal:  Curr Rheumatol Rep       Date:  2017-06       Impact factor: 4.592

5.  Reversible retiform purpura: a sign of cocaine use.

Authors:  Christina Han; Gayatri Sreenivasan; Jan P Dutz
Journal:  CMAJ       Date:  2011-03-14       Impact factor: 8.262

6.  A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine.

Authors:  Rachel L Gross; Jason Brucker; Asena Bahce-Altuntas; Maria A Abadi; Jules Lipoff; David Kotlyar; Peter Barland; Chaim Putterman
Journal:  Clin Rheumatol       Date:  2011-06-25       Impact factor: 2.980

7.  Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease.

Authors:  Martina M McGrath; Tamara Isakova; Helmut G Rennke; Ann M Mottola; Karen A Laliberte; John L Niles
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-06       Impact factor: 8.237

Review 8.  Systemic sclerosis induced by the use of cocaine: is there an association?

Authors:  Rafael Andreussi; Lila Morena Bueno Silva; Henrique Carriço da Silva; Ana Paula Luppino-Assad; Danieli Castro O Andrade; Percival D Sampaio-Barros
Journal:  Rheumatol Int       Date:  2018-12-15       Impact factor: 2.631

9.  Characteristic purpura of the ears, vasculitis, and neutropenia--a potential public health epidemic associated with levamisole-adulterated cocaine.

Authors:  Catherine Chung; Paul C Tumeh; Ron Birnbaum; Belinda H Tan; Linda Sharp; Erin McCoy; Mary Gail Mercurio; Noah Craft
Journal:  J Am Acad Dermatol       Date:  2011-06-11       Impact factor: 11.527

Review 10.  Non-chemotherapy drug-induced neutropenia: key points to manage the challenges.

Authors:  Brian R Curtis
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.